Macroautophagy and ERK phosphorylation counteract the antiproliferative effect of proteasome inhibitor in gastric cancer cells
Publication in refereed journal


引用次數
替代計量分析
.

其它資訊
摘要The ubiquitin-proteasome system and macroautophagy are two complementary pathways for protein degradation. Emerging evidence suggests that proteasome inhibition might be a promising approach for the treatment of cancer. In this study, we show that proteasome inhibitor MG-132 suppressed gastric cancer cell proliferation and induced macroautophagy. The induction of macroautophagy was evidenced by the formation of LC3(+) autophagosomes and the accumulation of acidic vesicular organelles and autolysosomes and was accompanied by the suppression of mammalian target of rapamycin complex 1 activity. Abolition of macroautophagy by knockdown of Class III phosphatidylinositol-3 kinase Vps34 or ATG5/7 sensitized gastric cancer cells to the antiproliferative effect of MG-132 by promoting G(2)/M cell cycle arrest. In addition, MG-132 increased ERK phosphorylation whose inhibition by MEK inhibitor significantly enhanced the antiproliferative effect of proteasome inhibition. To conclude, this study demonstrates that macroautophagy and ERK phosphorylation serve as protective mechanisms to counteract the antiproliferative effect of proteasome inhibition. This discovery may have implication in the application of proteasome-directed therapy for the treatment of cancer.
著者Wu WKK, Cho CH, Lee CW, Wu YC, Yu L, Li ZJ, Wong CCM, Li HT, Zhang L, Ren SX, Che CT, Wu KC, Fan DM, Yu J, Sung JJY
期刊名稱Autophagy
詳細描述(CHC as Co-correspondence author)
出版年份2010
月份2
日期16
卷號6
期次2
出版社Taylor & Francis: STM, Behavioural Science and Public Health Titles
頁次228 - 238
國際標準期刊號1554-8627
電子國際標準期刊號1554-8635
語言英式英語
關鍵詞autophagy; ERK; gastric cancer; proliferation; proteasome inhibitor
Web of Science 學科類別Cell Biology; CELL BIOLOGY

上次更新時間 2021-20-01 於 00:50